Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Other Non Operating Income: 2022-2024

Historic Other Non Operating Income for Dianthus Therapeutics (DNTH) over the last 3 years, with Dec 2024 value amounting to -$554,000.

  • Dianthus Therapeutics' Other Non Operating Income fell 650.00% to -$360,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$947,000, marking a year-over-year decrease of 245.62%. This contributed to the annual value of -$554,000 for FY2024, which is 551.76% down from last year.
  • Latest data reveals that Dianthus Therapeutics reported Other Non Operating Income of -$554,000 as of FY2024, which was down 551.76% from -$85,000 recorded in FY2023.
  • Dianthus Therapeutics' 5-year Other Non Operating Income high stood at $136,000 for FY2022, and its period low was -$554,000 during FY2024.
  • For the 3-year period, Dianthus Therapeutics' Other Non Operating Income averaged around -$167,667, with its median value being -$85,000 (2023).
  • Data for Dianthus Therapeutics' Other Non Operating Income shows a maximum YoY slumped of 551.76% (in 2024) over the last 5 years.
  • Dianthus Therapeutics' Other Non Operating Income (Yearly) stood at $136,000 in 2022, then plummeted by 162.50% to -$85,000 in 2023, then plummeted by 551.76% to -$554,000 in 2024.